Longitude Capital Management Co. LLC purchased $4.8M worth of shares in Aptinyx, Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Longitude Capital specializes in investments in medical devices, biotechnology and pharmaceutical development. They consider companies across all therapeutic indications and stages of development.
Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.